Whalesbook
Q4 Earnings Drive Stock Surge
SRF Limited saw its stock price jump nearly 8% on Wednesday, May 6, 2026, marking its largest single-day gain in over a year. The surge followed strong financial results for the quarter ended March 31, 2026. Consolidated revenue grew 7% year-on-year to ₹4,615 crore, while profit after tax (PAT) increased by a faster 11% to ₹582 crore, suggesting improved profitability. For the full fiscal year 2026, SRF reported 7% revenue growth to ₹15,787 crore and a significant 47% jump in PAT to ₹1,835 crore, driven by a 29% rise in operational EBIT. Key segments, particularly Chemicals and Performance Films & Foil, contributed to this performance. The Chemicals segment revenue rose 4% to ₹2,448 crore, supported by Fluorochemicals and Specialty Chemicals. Performance Films & Foil revenue surged 13% to ₹1,596 crore, boosted by higher volumes and margins in BOPET and BOPP films.
Massive Refrigerant Capex Plan Approved
Beyond quarterly results, SRF's board approved significant shifts in its capital expenditure plans. The company indefinitely deferred a proposed ₹490 crore BOPP Film manufacturing facility in Indore, citing changes in the operating environment. In contrast, it revised upwards its investment for a new generation Refrigerants project in Odisha to approximately ₹2,300 crore, up from ₹1,100 crore. This phased project includes a 20,000 tonnes per annum HFO facility and a 30,000 tonnes per annum HF plant, with completion expected by February 2028. An additional ₹88 crore expansion for HFC capacity at Dahej was also approved. These decisions represent a significant strategic shift, with the company doubling down on refrigerants while scaling back on certain film capacities. Management also noted that exports to the Middle East were impacted during the quarter, with Chairman and Managing Director Ashish Bharat Ram citing global uncertainty as a key concern.
Valuation Concerns and Stock Lag
Despite the recent rally, SRF's stock has significantly underperformed over the past year, declining 14.65% while the broader BSE 500 index gained 3.23%. The stock's current P/E ratio, trading between 42x and 51x on a trailing twelve-month (TTM) basis, places it at a premium compared to the chemical sector average P/E of 55.42x. Analysts generally maintain 'buy' or 'outperform' ratings with an average 1-year price target around ₹3,100-₹3,138. This optimism contrasts with historical earnings trends, which saw an average annual decline of 1.6% over five years, accelerating to 55.1% last year, far exceeding the chemical industry's 7.9% average. This elevated valuation, coupled with the stock's recent performance, suggests the market expects substantial future growth and successful execution of its ambitious capex plans.
Execution Risks and Market Challenges
The substantial increase in the refrigerants project capex to ₹2,300 crore, while potentially lucrative, introduces considerable execution risk and financial strain, especially given the volatile global economy and global uncertainties flagged by management. Unlike competitors such as Aarti Industries or Navin Fluorine, which may have more diversified or less capital-intensive growth strategies, SRF is making a large, concentrated investment. The deferment of the Indore BOPP facility also raises questions about SRF's market adaptability or if it was a missed opportunity. Furthermore, the Indian chemical sector faces global challenges like overcapacity, margin pressure, and trade fragmentation. SRF's past earnings decline and its recent year-long stock underperformance highlight its vulnerability to these macro factors, suggesting the current rally might not be sustainable if operational challenges or capex execution falter. Foreign institutional holdings decreased from 17.48% to 16.67% during the period, even as domestic institutional holdings increased.
Outlook: Balancing Growth and Uncertainty
Looking ahead, SRF faces a delicate balancing act. Analysts project potential upside from current levels, anticipating successful integration of new projects and ongoing operational improvements. SRF's focus on specialty chemicals and high-value products aligns with the Indian chemical industry's growth trajectory, expected to outpace GDP. However, management's acknowledged concerns regarding geopolitical instability and export impacts cannot be dismissed. Successfully delivering the ₹2,300 crore refrigerants project will be crucial to justify SRF's current valuation and drive future returns in a complex global market.